Those Who Invested in Stryker (NYSE:SYK) Five Years Ago Are up 60%
Those Who Invested in Stryker (NYSE:SYK) Five Years Ago Are up 60%
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Stryker Corporation (NYSE:SYK) share price is up 51% in the last five years, that's less than the market return. Zooming in, the stock is up a respectable 15% in the last year.
如果您购买并持有一支股票多年,希望能获得利润。此外,您通常希望看到股价上涨比市场快。不幸的是,对于股东而言,尽管Stryker Corporation (纽交所:SYK)的股价在过去五年中上涨了51%,但仍低于市场回报。缩小范围后,股票在过去一年中上涨了15%。
So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns.
因此,让我们评估过去5年的基本面,看看它们是否和股东的回报率相符。
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.
为了概述本杰明·格雷厄姆(Benjamin Graham)的话:短期内,市场是一台投票机,但长期来看,它是一台衡重机。思考一家公司的市场感知如何转变的一种不完美但简单的方法是将每股收益(EPS)变化与股价变动进行比较。
Stryker's earnings per share are down 1.0% per year, despite strong share price performance over five years.
尽管在过去五年中股价表现强劲,但Stryker的每股收益年降1.0%。
So it's hard to argue that the earnings per share are the best metric to judge the company, as it may not be optimized for profits at this point. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.
因此,很难说每股收益是评判公司的最佳指标,因为此时它可能没有针对利润进行优化。由于每股收益的变化似乎与股价的变化无关,因此值得查看其他指标。
The modest 1.0% dividend yield is unlikely to be propping up the share price. In contrast revenue growth of 9.0% per year is probably viewed as evidence that Stryker is growing, a real positive. It's quite possible that management are prioritizing revenue growth over EPS growth at the moment.
适度的1.0%红利收益率不可能撑起股价。相比之下,年增长率达9.0%的营业收入可能被视为Stryker正在增长的证据,并具有真正的积极意义。目前管理层很有可能将营收增长置于每股收益增长之上。
The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).
下图显示了收益和营收随时间变化的情况(如果你点击图像,可以看到更多细节):
Stryker is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. Given we have quite a good number of analyst forecasts, it might be well worth checking out this free chart depicting consensus estimates.
Stryker是一支广受关注的股票,有许多分析师关注,表明对未来增长有一定的可见度。鉴于我们有相当数量的分析师预测,查看这个免费的图表以呈现共识预测可能非常值得。
What About Dividends?
那么分红怎么样呢?
As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Stryker the TSR over the last 5 years was 60%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!
除了衡量股价回报,投资者还应考虑总股东回报(TSR)。 TSR包括任何分拆价值或折价募资价值,以及根据股息再投资假设计算的任何股息。可以说TSR给出了一个更全面的股票回报图景。我们注意到,在过去的5年中,Stryker的TSR为60%,优于上述股价回报。这在很大程度上是其股息支付的结果!
A Different Perspective
不同的观点
Stryker shareholders are up 17% for the year (even including dividends). But that return falls short of the market. The silver lining is that the gain was actually better than the average annual return of 10% per year over five year. This could indicate that the company is winning over new investors, as it pursues its strategy. It's always interesting to track share price performance over the longer term. But to understand Stryker better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Stryker you should know about.
即使包括股息,Stryker的股东今年仅获得了17%的回报,但该回报仍低于市场。积极的一面是,该增长实际上比过去5年的平均年回报率10%更好。这可能表明,随着公司推进其策略,公司正在赢得新投资者的青睐。跟踪较长期的股价表现始终很有趣。但为了更好地了解Stryker,我们需要考虑许多其他因素。例如,考虑风险。每个公司都有风险,我们已经发现Stryker有2个值得注意的警告信号,您应该了解。
If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).
如果您喜欢与管理层一起购买股票,那么您可能会喜欢这个公司的免费列表。 (提示:其中许多公司不为人注意且具有吸引力的估值。)
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文所引述的市场回报反映了目前在美国交易所上市的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。